Messe Steven

Messe Steven, doing business as Steven Messe Medical Consulting, is a sole proprietorship based in Wynnewood, Pennsylvania that provides medical expert case review and consulting services to support the Vaccine Injury Compensation Program (VICP) and Countermeasures Injury Compensation Program (CICP) administered by the Department of Health and Human Services' Health Resources and Services Administration. The vendor operates exclusively as a prime contractor (100% of recent awards) under total small business set-aside designations on blanket purchase agreements, with a single recent outlier award from the Department of Justice Civil Division.

The medical case review work is narrowly focused on individual VICP claim adjudication. Representative awards include a $11.25 thousand firm fixed-price BPA call issued March 16, 2026 for medical expert consulting supporting VICP and CICP (completion February 15, 2027), a $4.5 thousand BPA call from May 2023 for medical expert services on VICP Case 20-1222, and a $3.75 thousand call from August 2022 for expert review of VICP Case 21-1568. All named awards carry typical completion windows of six to twelve months and are performed at the Wynnewood location. The vendor's categorization under PSC Support–Professional: Expert Witness and NAICS Offices of Physicians reflects the clinical-review nature of the engagement rather than operational practice.

Customer concentration is extreme: 25 of 26 awards (96% of combined potential value at $728 thousand) flow from HRSA Headquarters, with a single $3 thousand award from the Department of Justice Civil Division. The vendor operates under three parent BPAs, with work distributed across Blanket Purchase Agreement 75R60219A00099 (eight task orders, $23 thousand combined potential value), Blanket Purchase Agreement 75R60221A00060 (seven task orders, $35 thousand combined potential value), and the VICP Medical Expert Panel vehicle (seven task orders, $21 thousand combined potential value). Activity declined sharply from 2020–2021 (four to five awards per year) through 2022–2023 (one award in 2023), with a single award in 2026; combined dollars obligated total $82 thousand against $731 thousand combined potential value (11% realization). One award with combined potential value $11 thousand reaches ultimate completion within the next twenty-four months, creating limited recompete exposure.